According to Market IntelliX new research study, the global market for Adalimumab Injection should grow from US$ 1820 million in 2023 to US$ 2648.6 million by 2030, with a CAGR of 5.6% for the period of 2024-2030.

China Adalimumab Injection market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Adalimumab Injection market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, 40mg/0.8ml segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Hospitals has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.

The global key manufacturers of Adalimumab Injection include AbbVie, Amgen, Sandoz, Fresenius Kabi, Biogen, Celltrion, Cadila Pharmaceuticals, Bio-Thera Solutions, Ltd. and Hisun Biopharmaceutical, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Adalimumab Injection. Report Highlights:

(1) Global Adalimumab Injection market size (sales volume & revenue), history data from 2019-2023 and forecast data from 2024 to 2030.

(2) Global Adalimumab Injection market competitive situation, sales, revenue, price and market share, from 2019 to 2023.

(3) China Adalimumab Injection market competitive situation, sales, revenue, price and market share, from 2019 to 2023.

(4) Global Adalimumab Injection segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Adalimumab Injection segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Adalimumab Injection, capacity, production and trends.

(7) Adalimumab Injection industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

40mg/0.8ml

20mg/0.4ml

Market segment by application, can be divided into

Hospitals

Clinics

Others

Market segment by players, this report covers

AbbVie

Amgen

Sandoz

Fresenius Kabi

Biogen

Celltrion

Cadila Pharmaceuticals

Bio-Thera Solutions, Ltd.

Hisun Biopharmaceutical

Innovent Biologics

Mylan

Zydus Group

Boehringer Ingelheim

Jiangsu Chia Tai-Tianqing Pharmaceutical

Shanghai Henlius Biotech

1 Market Overview

1.1 Adalimumab Injection Definition

1.2 Global Adalimumab Injection Market Size and Forecast

1.2.1 By Revenue, Global Adalimumab Injection Market Size, 2019-2030

1.2.2 By Sales Volume, Global Adalimumab Injection Market Size, 2019-2030

1.2.3 Global Adalimumab Injection Price Trend, 2019-2030

1.3 China Adalimumab Injection Market Size and Forecast

1.3.1 By Revenue, China Adalimumab Injection Market Size, 2019-2030

1.3.2 By Sales Volume, China Adalimumab Injection Market Size, 2019-2030

1.3.3 China Adalimumab Injection Price Trend, 2019-2030

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Adalimumab Injection Share in Global Market, 2019-2030

1.4.2 By Sales Volume, China Adalimumab Injection Share in Global Market, 2019-2030

1.4.3 Adalimumab Injection Market Size: China VS Global, 2019-2030

1.5 Adalimumab Injection Market Dynamics

1.5.1 Adalimumab Injection Market Drivers

1.5.2 Adalimumab Injection Market Restraints

1.5.3 Adalimumab Injection Industry Trends

1.5.4 Adalimumab Injection Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Adalimumab Injection Revenue by Company, 2019-2023

2.2 Global Adalimumab Injection Sales Volume by Company, 2019-2023

2.3 Global Adalimumab Injection Price by Company, 2019-2023

2.4 Global Adalimumab Injection Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Adalimumab Injection Concentration Ratio

2.6 Global Adalimumab Injection Mergers & Acquisitions, Expansion Plans

2.7 Global Adalimumab Injection Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Adalimumab Injection Revenue by Company, 2019-2023

3.2 China Adalimumab Injection Sales Volume by Company, 2019-2023

3.3 China Adalimumab Injection Adalimumab Injection Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Adalimumab Injection Market, Sales Percentage of Local Players VS Foreign Players (2019-2023)

3.5 Chinese Local Players, Adalimumab Injection Domestic VS Export

3.6 China Market, Adalimumab Injection Import & Export

3.6.1 China Market, Adalimumab Injection Import & Export, 2019-2030

3.6.2 China Adalimumab Injection Import & Export Trends

3.6.3 Main Sources of China Adalimumab Injection Import

3.6.4 Export Destination of China Adalimumab Injection

4 Adalimumab Injection Production by Region

4.1 Global Adalimumab Injection Capacity, Production and Capacity Utilization, 2019-2030

4.2 Global Geographic Distribution of Adalimumab Injection Manufacturers

4.3 Global Major Manufacturers, Adalimumab Injection Capacity Expansion and Future Plans

4.4 Global Adalimumab Injection Capacity by Region

4.5 Global Adalimumab Injection Production by Region

4.5.1 Global Adalimumab Injection Production & Forecast by Region, 2019 VS 2023 VS 2030

4.5.2 Global Adalimumab Injection Production by Region, 2019-2023

4.5.3 Global Adalimumab Injection Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 Adalimumab Injection Industry Chain

5.2 Adalimumab Injection Upstream Analysis

5.2.1 Adalimumab Injection Core Raw Materials

5.2.2 Main Manufacturers of Adalimumab Injection Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Adalimumab Injection Production Mode

5.6 Adalimumab Injection Procurement Model

5.7 Adalimumab Injection Industry Sales Model and Sales Channels

5.7.1 Adalimumab Injection Sales Model

5.7.2 Adalimumab Injection Typical Distributors

6 Sights by Type

6.1 Adalimumab Injection Classification

6.1.1 40mg/0.8ml

6.1.2 20mg/0.4ml

6.2 By Type, Global Adalimumab Injection Market Size & CAGR, 2019 VS 2023 VS 2030

6.3 By Type, Global Adalimumab Injection Revenue, 2019-2030

6.4 By Type, Global Adalimumab Injection Sales Volume, 2019-2030

6.5 By Type, Global Adalimumab Injection Price, 2019-2030

7 Sights by Application

7.1 Adalimumab Injection Segment by Application

7.1.1 Hospitals

7.1.2 Clinics

7.1.3 Others

7.2 By Application, Global Adalimumab Injection Market Size & CAGR, 2019 VS 2023 VS 2030

7.3 By Application, Global Adalimumab Injection Revenue, 2019-2030

7.4 By Application, Global Adalimumab Injection Sales Volume, 2019-2030

7.5 By Application, Global Adalimumab Injection Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global Adalimumab Injection Market Size, 2019 VS 2023 VS 2030

8.2 By Region, Global Adalimumab Injection Revenue, 2019-2030

8.3 By Region, Global Adalimumab Injection Sales Volume, 2019-2030

8.4 North America

8.4.1 North America Adalimumab Injection Market Size & Forecasts, 2019-2030

8.4.2 By Country, North America Adalimumab Injection Market Size Market Share

8.5 Europe

8.5.1 Europe Adalimumab Injection Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe Adalimumab Injection Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Adalimumab Injection Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific Adalimumab Injection Market Size Market Share

8.7 South America

8.7.1 South America Adalimumab Injection Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America Adalimumab Injection Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Adalimumab Injection Market Size & CAGR，2019 VS 2023 VS 2030

9.2 By Country, Global Adalimumab Injection Revenue, 2019-2030

9.3 By Country, Global Adalimumab Injection Sales Volume, 2019-2030

9.4 U.S.

9.4.1 U.S. Adalimumab Injection Market Size, 2019-2030

9.4.2 By Company, U.S. Adalimumab Injection Sales Volume Market Share, 2023

9.4.3 By Type, U.S. Adalimumab Injection Market Size, Share, 2023 VS 2030

9.4.4 By Application, U.S. Adalimumab Injection Market Size, Share, 2023 VS 2030

9.5 Europe

9.5.1 Europe Adalimumab Injection Market Size, 2019-2030

9.5.2 By Company, Europe Adalimumab Injection Sales Volume Market Share, 2023

9.5.3 By Type, Europe Adalimumab Injection Market Size, Share, 2023 VS 2030

9.5.4 By Application, Europe Adalimumab Injection Market Size, Share, 2023 VS 2030

9.6 China

9.6.1 China Adalimumab Injection Market Size, 2019-2030

9.6.2 By Company, China Adalimumab Injection Sales Volume Market Share, 2023

9.6.3 By Type, China Adalimumab Injection Market Size, Share, 2023 VS 2030

9.6.4 By Application, China Adalimumab Injection Market Size, Share, 2023 VS 2030

9.7 Japan

9.7.1 Japan Adalimumab Injection Market Size, 2019-2030

9.7.2 By Company, Japan Adalimumab Injection Sales Volume Market Share, 2023

9.7.3 By Type, Japan Adalimumab Injection Market Size, Share, 2023 VS 2030

9.7.4 By Application, Japan Adalimumab Injection Market Size, Share, 2023 VS 2030

9.8 South Korea

9.8.1 South Korea Adalimumab Injection Market Size, 2019-2030

9.8.2 By Company, South Korea Adalimumab Injection Sales Volume Market Share, 2023

9.8.3 By Type, South Korea Adalimumab Injection Market Size, Share, 2023 VS 2030

9.8.4 By Application, South Korea Adalimumab Injection Market Size, Share, 2023 VS 2030

9.9 Southeast Asia

9.9.1 Southeast Asia Adalimumab Injection Market Size, 2019-2030

9.9.2 By Company, Southeast Asia Adalimumab Injection Sales Volume Market Share, 2023

9.9.3 By Type, Southeast Asia Adalimumab Injection Market Size, Share, 2023 VS 2030

9.9.4 By Application, Southeast Asia Adalimumab Injection Market Size, Share, 2023 VS 2030

9.10 India

9.10.1 India Adalimumab Injection Market Size, 2019-2030

9.10.2 By Company, India Adalimumab Injection Sales Volume Market Share, 2023

9.10.3 By Type, India Adalimumab Injection Market Size, Share, 2023 VS 2030

9.10.4 By Application, India Adalimumab Injection Market Size, Share, 2023 VS 2030

9.11 Middle East & Asia

9.11.1 Middle East & Asia Adalimumab Injection Market Size, 2019-2030

9.11.2 By Company, Middle East & Asia Adalimumab Injection Sales Volume Market Share, 2023

9.11.3 By Type, Middle East & Asia Adalimumab Injection Market Size, Share, 2023 VS 2030

9.11.4 By Application, Middle East & Asia Adalimumab Injection Market Size, Share, 2023 VS 2030

10 Manufacturers Profile

10.1 AbbVie

10.1.1 AbbVie Company Information, Head Office, Market Area and Industry Position

10.1.2 AbbVie Adalimumab Injection Models, Specifications and Application

10.1.3 AbbVie Adalimumab Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.1.4 AbbVie Company Profile and Main Business

10.1.5 AbbVie Recent Developments

10.2 Amgen

10.2.1 Amgen Company Information, Head Office, Market Area and Industry Position

10.2.2 Amgen Adalimumab Injection Models, Specifications and Application

10.2.3 Amgen Adalimumab Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.2.4 Amgen Company Profile and Main Business

10.2.5 Amgen Recent Developments

10.3 Sandoz

10.3.1 Sandoz Company Information, Head Office, Market Area and Industry Position

10.3.2 Sandoz Adalimumab Injection Models, Specifications and Application

10.3.3 Sandoz Adalimumab Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.3.4 Sandoz Company Profile and Main Business

10.3.5 Sandoz Recent Developments

10.4 Fresenius Kabi

10.4.1 Fresenius Kabi Company Information, Head Office, Market Area and Industry Position

10.4.2 Fresenius Kabi Adalimumab Injection Models, Specifications and Application

10.4.3 Fresenius Kabi Adalimumab Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.4.4 Fresenius Kabi Company Profile and Main Business

10.4.5 Fresenius Kabi Recent Developments

10.5 Biogen

10.5.1 Biogen Company Information, Head Office, Market Area and Industry Position

10.5.2 Biogen Adalimumab Injection Models, Specifications and Application

10.5.3 Biogen Adalimumab Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.5.4 Biogen Company Profile and Main Business

10.5.5 Biogen Recent Developments

10.6 Celltrion

10.6.1 Celltrion Company Information, Head Office, Market Area and Industry Position

10.6.2 Celltrion Adalimumab Injection Models, Specifications and Application

10.6.3 Celltrion Adalimumab Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.6.4 Celltrion Company Profile and Main Business

10.6.5 Celltrion Recent Developments

10.7 Cadila Pharmaceuticals

10.7.1 Cadila Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

10.7.2 Cadila Pharmaceuticals Adalimumab Injection Models, Specifications and Application

10.7.3 Cadila Pharmaceuticals Adalimumab Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.7.4 Cadila Pharmaceuticals Company Profile and Main Business

10.7.5 Cadila Pharmaceuticals Recent Developments

10.8 Bio-Thera Solutions, Ltd.

10.8.1 Bio-Thera Solutions, Ltd. Company Information, Head Office, Market Area and Industry Position

10.8.2 Bio-Thera Solutions, Ltd. Adalimumab Injection Models, Specifications and Application

10.8.3 Bio-Thera Solutions, Ltd. Adalimumab Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.8.4 Bio-Thera Solutions, Ltd. Company Profile and Main Business

10.8.5 Bio-Thera Solutions, Ltd. Recent Developments

10.9 Hisun Biopharmaceutical

10.9.1 Hisun Biopharmaceutical Company Information, Head Office, Market Area and Industry Position

10.9.2 Hisun Biopharmaceutical Adalimumab Injection Models, Specifications and Application

10.9.3 Hisun Biopharmaceutical Adalimumab Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.9.4 Hisun Biopharmaceutical Company Profile and Main Business

10.9.5 Hisun Biopharmaceutical Recent Developments

10.10 Innovent Biologics

10.10.1 Innovent Biologics Company Information, Head Office, Market Area and Industry Position

10.10.2 Innovent Biologics Adalimumab Injection Models, Specifications and Application

10.10.3 Innovent Biologics Adalimumab Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.10.4 Innovent Biologics Company Profile and Main Business

10.10.5 Innovent Biologics Recent Developments

10.11 Mylan

10.11.1 Mylan Company Information, Head Office, Market Area and Industry Position

10.11.2 Mylan Adalimumab Injection Models, Specifications and Application

10.11.3 Mylan Adalimumab Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.11.4 Mylan Company Profile and Main Business

10.11.5 Mylan Recent Developments

10.12 Zydus Group

10.12.1 Zydus Group Company Information, Head Office, Market Area and Industry Position

10.12.2 Zydus Group Adalimumab Injection Models, Specifications and Application

10.12.3 Zydus Group Adalimumab Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.12.4 Zydus Group Company Profile and Main Business

10.12.5 Zydus Group Recent Developments

10.13 Boehringer Ingelheim

10.13.1 Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position

10.13.2 Boehringer Ingelheim Adalimumab Injection Models, Specifications and Application

10.13.3 Boehringer Ingelheim Adalimumab Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.13.4 Boehringer Ingelheim Company Profile and Main Business

10.13.5 Boehringer Ingelheim Recent Developments

10.14 Jiangsu Chia Tai-Tianqing Pharmaceutical

10.14.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.14.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Models, Specifications and Application

10.14.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.14.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Company Profile and Main Business

10.14.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments

10.15 Shanghai Henlius Biotech

10.15.1 Shanghai Henlius Biotech Company Information, Head Office, Market Area and Industry Position

10.15.2 Shanghai Henlius Biotech Adalimumab Injection Models, Specifications and Application

10.15.3 Shanghai Henlius Biotech Adalimumab Injection Sales Volume, Revenue, Price and Gross Margin, 2019-2023

10.15.4 Shanghai Henlius Biotech Company Profile and Main Business

10.15.5 Shanghai Henlius Biotech Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Adalimumab Injection Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Adalimumab Injection Market Restraints

Table 3. Adalimumab Injection Market Trends

Table 4. Adalimumab Injection Industry Policy

Table 5. Global Adalimumab Injection Revenue by Company, 2019-2023, US$ million

Table 6. Global Adalimumab Injection Revenue Market Share by Company, 2019-2023

Table 7. Global Adalimumab Injection Sales Volume by Company, 2019-2023, (K Units)

Table 8. Global Adalimumab Injection Sales Volume Market Share by Company, 2019-2023

Table 9. Global Adalimumab Injection Price by Company, 2019-2023, (US$/Unit)

Table 10. Global Adalimumab Injection Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Adalimumab Injection Mergers & Acquisitions, Expansion Plans

Table 12. Global Adalimumab Injection Manufacturers Product Type

Table 13. China Adalimumab Injection Revenue by Company, 2019-2023, US$ million

Table 14. China Adalimumab Injection Revenue Market Share by Company, 2019-2023

Table 15. China Adalimumab Injection Sales Volume by Company, 2019-2023, (K Units)

Table 16. China Adalimumab Injection Sales Volume Market Share by Company, 2019-2023

Table 17. China Market, Adalimumab Injection Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Adalimumab Injection Import & Export Trends

Table 19. Main Sources of China Adalimumab Injection Import

Table 20. Export Destination of China Adalimumab Injection

Table 21. Global Headquarters and Manufacturing Base of Adalimumab Injection Manufacturers

Table 22. Global Major Manufacturers, Adalimumab Injection Capacity Expansion and Future Plans

Table 23. Global Adalimumab Injection Production & Forecast by Region, 2019 VS 2023 VS 2030, (K Units)

Table 24. Global Adalimumab Injection Production by Region, 2019-2023, (K Units)

Table 25. Global Adalimumab Injection Production Forecast by Region, 2023-2030, (K Units)

Table 26. Global Key Players of Adalimumab Injection Upstream (Raw Materials)

Table 27. Global Adalimumab Injection Typical Customers

Table 28. Adalimumab Injection Typical Distributors

Table 29. By Type, Global Adalimumab Injection Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 30. By Application, Global Adalimumab Injection Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 31. By Region, Global Adalimumab Injection Market Size, 2019 VS 2023 VS 2030, US$ Million

Table 32. By Region, Global Adalimumab Injection Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Adalimumab Injection Revenue & CAGR，2019 VS 2023 VS 2030, US$ Million

Table 35. By Country, Global Adalimumab Injection Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Adalimumab Injection Revenue Market Share, 2019-2030

Table 37. By Country, Global Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Adalimumab Injection Sales Volume Market Share, 2019-2030

Table 39. AbbVie Company Information, Head Office, Market Area and Industry Position

Table 40. AbbVie Adalimumab Injection Models, Specifications and Application

Table 41. AbbVie Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 42. AbbVie Company Profile and Main Business

Table 43. AbbVie Recent Developments

Table 44. Amgen Company Information, Head Office, Market Area and Industry Position

Table 45. Amgen Adalimumab Injection Models, Specifications and Application

Table 46. Amgen Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 47. Amgen Company Profile and Main Business

Table 48. Amgen Recent Developments

Table 49. Sandoz Company Information, Head Office, Market Area and Industry Position

Table 50. Sandoz Adalimumab Injection Models, Specifications and Application

Table 51. Sandoz Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 52. Sandoz Company Profile and Main Business

Table 53. Sandoz Recent Developments

Table 54. Fresenius Kabi Company Information, Head Office, Market Area and Industry Position

Table 55. Fresenius Kabi Adalimumab Injection Models, Specifications and Application

Table 56. Fresenius Kabi Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 57. Fresenius Kabi Company Profile and Main Business

Table 58. Fresenius Kabi Recent Developments

Table 59. Biogen Company Information, Head Office, Market Area and Industry Position

Table 60. Biogen Adalimumab Injection Models, Specifications and Application

Table 61. Biogen Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 62. Biogen Company Profile and Main Business

Table 63. Biogen Recent Developments

Table 64. Celltrion Company Information, Head Office, Market Area and Industry Position

Table 65. Celltrion Adalimumab Injection Models, Specifications and Application

Table 66. Celltrion Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 67. Celltrion Company Profile and Main Business

Table 68. Celltrion Recent Developments

Table 69. Cadila Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 70. Cadila Pharmaceuticals Adalimumab Injection Models, Specifications and Application

Table 71. Cadila Pharmaceuticals Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 72. Cadila Pharmaceuticals Company Profile and Main Business

Table 73. Cadila Pharmaceuticals Recent Developments

Table 74. Bio-Thera Solutions, Ltd. Company Information, Head Office, Market Area and Industry Position

Table 75. Bio-Thera Solutions, Ltd. Adalimumab Injection Models, Specifications and Application

Table 76. Bio-Thera Solutions, Ltd. Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 77. Bio-Thera Solutions, Ltd. Company Profile and Main Business

Table 78. Bio-Thera Solutions, Ltd. Recent Developments

Table 79. Hisun Biopharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 80. Hisun Biopharmaceutical Adalimumab Injection Models, Specifications and Application

Table 81. Hisun Biopharmaceutical Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 82. Hisun Biopharmaceutical Company Profile and Main Business

Table 83. Hisun Biopharmaceutical Recent Developments

Table 84. Innovent Biologics Company Information, Head Office, Market Area and Industry Position

Table 85. Innovent Biologics Adalimumab Injection Models, Specifications and Application

Table 86. Innovent Biologics Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 87. Innovent Biologics Company Profile and Main Business

Table 88. Innovent Biologics Recent Developments

Table 89. Mylan Company Information, Head Office, Market Area and Industry Position

Table 90. Mylan Adalimumab Injection Models, Specifications and Application

Table 91. Mylan Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 92. Mylan Company Profile and Main Business

Table 93. Mylan Recent Developments

Table 94. Zydus Group Company Information, Head Office, Market Area and Industry Position

Table 95. Zydus Group Adalimumab Injection Models, Specifications and Application

Table 96. Zydus Group Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 97. Zydus Group Company Profile and Main Business

Table 98. Zydus Group Recent Developments

Table 99. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position

Table 100. Boehringer Ingelheim Adalimumab Injection Models, Specifications and Application

Table 101. Boehringer Ingelheim Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 102. Boehringer Ingelheim Company Profile and Main Business

Table 103. Boehringer Ingelheim Recent Developments

Table 104. Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 105. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Models, Specifications and Application

Table 106. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 107. Jiangsu Chia Tai-Tianqing Pharmaceutical Company Profile and Main Business

Table 108. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments

Table 109. Shanghai Henlius Biotech Company Information, Head Office, Market Area and Industry Position

Table 110. Shanghai Henlius Biotech Adalimumab Injection Models, Specifications and Application

Table 111. Shanghai Henlius Biotech Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 112. Shanghai Henlius Biotech Company Profile and Main Business

Table 113. Shanghai Henlius Biotech Recent Developments

List of Figure

Figure 1. Adalimumab Injection Picture

Figure 2. By Revenue, Global Adalimumab Injection Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Adalimumab Injection Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Adalimumab Injection Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Adalimumab Injection Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Adalimumab Injection Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Adalimumab Injection Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Adalimumab Injection Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Adalimumab Injection Share of Global Market, 2019-2030

Figure 10. Global Adalimumab Injection Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 11. Global Adalimumab Injection Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2023

Figure 12. China Adalimumab Injection Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 13. China Adalimumab Injection Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 14. China Adalimumab Injection Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2023

Figure 15. Chinese Local Players, Proportion of Adalimumab Injection Domestic VS Export, 2023

Figure 16. Global Adalimumab Injection Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Adalimumab Injection Capacity Market Share by Region, 2023 VS 2030

Figure 18. Global Adalimumab Injection Production Market Share & Forecast by Region, 2019-2030

Figure 19. Adalimumab Injection Industry Chain

Figure 20. Adalimumab Injection Procurement Model

Figure 21. Adalimumab Injection Sales Model

Figure 22. Adalimumab Injection Sales Channels, Direct Sales and Distribution

Figure 23. 40mg/0.8ml

Figure 24. 20mg/0.4ml

Figure 25. By Type, Global Adalimumab Injection Revenue, 2019-2030, US$ Million

Figure 26. By Type, Global Adalimumab Injection Revenue Market Share, 2019-2030

Figure 27. By Type, Global Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 28. By Type, Global Adalimumab Injection Sales Volume Market Share, 2019-2030

Figure 29. By Type, Global Adalimumab Injection Price, 2019-2030, (US$/Unit)

Figure 30. Hospitals

Figure 31. Clinics

Figure 32. Others

Figure 33. By Application, Global Adalimumab Injection Revenue, 2019-2030, US$ Million

Figure 34. By Application, Global Adalimumab Injection Revenue Market Share, 2019-2030

Figure 35. By Application, Global Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 36. By Application, Global Adalimumab Injection Sales Volume Market Share, 2019-2030

Figure 37. By Application, Global Adalimumab Injection Price, 2019-2030, (US$/Unit)

Figure 38. By Region, Global Adalimumab Injection Revenue Market Share, 2019-2030

Figure 39. By Region, Global Adalimumab Injection Sales Volume Market Share, 2019-2030

Figure 40. North America Adalimumab Injection Revenue & Forecasts, 2019-2030, US$ Million

Figure 41. By Country, North America Adalimumab Injection Revenue Market Share, 2023

Figure 42. Europe Adalimumab Injection Revenue & Forecasts, 2019-2030, US$ Million

Figure 43. By Country, Europe Adalimumab Injection Revenue Market Share, 2023

Figure 44. Asia Pacific Adalimumab Injection Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country/Region, Asia Pacific Adalimumab Injection Revenue Market Share, 2023

Figure 46. South America Adalimumab Injection Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country, South America Adalimumab Injection Revenue Market Share, 2023

Figure 48. Middle East & Africa Adalimumab Injection Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. U.S. Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 50. By Company, U.S. Adalimumab Injection Market Share, 2023

Figure 51. By Type, U.S. Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 52. By Application, U.S. Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 53. Europe Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 54. By Company, Europe Adalimumab Injection Market Share, 2023

Figure 55. By Type, Europe Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 56. By Application, Europe Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 57. China Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 58. By Company, China Adalimumab Injection Market Share, 2023

Figure 59. By Type, China Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 60. By Application, China Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 61. Japan Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 62. By Company, Japan Adalimumab Injection Market Share, 2023

Figure 63. By Type, Japan Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 64. By Application, Japan Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 65. South Korea Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 66. By Company, South Korea Adalimumab Injection Market Share, 2023

Figure 67. By Type, South Korea Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 68. By Application, South Korea Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 69. Southeast Asia Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 70. By Company, Southeast Asia Adalimumab Injection Market Share, 2023

Figure 71. By Type, Southeast Asia Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 72. By Application, Southeast Asia Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 73. India Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 74. By Company, India Adalimumab Injection Market Share, 2023

Figure 75. By Type, India Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 76. By Application, India Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 77. Middle East & Asia Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 78. By Company, Middle East & Asia Adalimumab Injection Market Share, 2023

Figure 79. By Type, Middle East & Asia Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 80. By Application, Middle East & Asia Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 81. Research Methodology

Figure 82. Breakdown of Primary Interviews

Figure 83. Bottom-up Approaches

Figure 84. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)